Coinbase Founder’s Longevity Startup Triples in Value

Date:




Now worth $3.1 billion, NewLimit plans to test its RNA therapy in alcohol-related liver-disease patients next year.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Woman leaps from 11th-floor ledge into firefighter’s arms as Berlin high-rise burns

As a furious blaze raged inside a high-rise apartment...

NMSP investigating officer-involved shooting in Mora

MORA COUNTY, N.M. (KRQE) – New Mexico State Police are...

Opinion | Sheinbaum Moves to Gag Mexico’s Media

The president insists she backs democratic norms, but individual...